Among American men, prostate cancer is the most common non-skin cancer and the second leading cause of cancer death, exceeded only by lung cancer. In 2010, medical costs associated with prostate cancer were estimated at $12 billion - the fifth highest cost for any cancer site - with total cancer costs in the United States amounting to nearly $125 billion. The significant financial burden of cancer, compounded with the emotional strain of diagnosis and treatment, can create a complex situation for employers. This Action Brief outlines the scope of prostate cancer as well as how health plans are addressing the issues based on data from eValue8. Lastly, the brief highlights actions employers can take to educate its workforce about screening options and improve quality of life while reducing treatment costs for those facing a prostate cancer diagnosis.
Access the latest in NBCH's series of Action Briefs
here.
No comments:
Post a Comment